Page 7 - BH-3-1
P. 7

Brain & Heart





                                        REVIEW ARTICLE
                                        A contemporary review of transcatheter aortic

                                        valve replacement in low-gradient aortic
                                        stenosis



                                        Muhammad Majid  1,2  , Akiva Rosenzveig 1  , Elio Haroun 1  ,
                                        Aro Daniela Arockiam 1  , Ankit Agrawal 1  , Sharmeen Sorathia 1  ,
                                        Rochell Issa 1  , Tiffany Dong 1  , Nithila Sivakumar 1  , and
                                        Tom Kai Ming Wang *
                                                         1
                                        1 Department of Cardiovascular Medicine, Section of Cardiovascular Imaging, Heart, Vascular and
                                        Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
                                        2 Department of Internal Medicine, Advent Health Sebring, Sebring, Florida, United States of America
                                        (This article belongs to the Special Issue: Structural Heart Disease: Recent Updates)




                                        Abstract

                                        Transcatheter aortic valve replacement (TAVR) has been approved for patients
                                        with severe symptomatic aortic stenosis (AS) across the spectrum of surgical risk.
                                        Although there is substantial evidence regarding the utility of TAVR in patients
                                        with classic high-gradient symptomatic AS, the management of patients with
                                        discordant AS and gradients that are lower than expected remains uncertain. As
                                        low-gradient AS is quite prevalent, it warrants our attention. The TAVR approach in
            *Corresponding author:      these patients requires risk stratification and additional imaging modalities, such
            Tom Kai Ming Wang
            (wangt2@ccf.org)            as stress echocardiography, to more accurately evaluate the severity of AS. TAVR
                                        complications include stroke, kidney injury, conduction abnormalities, device-
            Citation: Majid M, Rosenzveig A,   related thrombosis, endocarditis, and mechanical or vascular complications, which
            Haroun E, et al. A contemporary
            review of transcatheter aortic   affect both patients with low- and high-gradient AS (HGAS). Contemporary research
            valve replacement in low-gradient   has demonstrated that TAVR is more effective in the low-gradient AS population
            aortic stenosis. Brain & Heart.   than in the HGAS population and shows better outcomes than conservative
            2025;3(1):4017.
            doi: 10.36922/bh.4017       management. The management of patients with AS, particularly low-gradient AS,
                                        remains poorly understood.
            Received: June 22, 2024
            Accepted: October 15, 2024
                                        Keywords: Transcatheter aortic valve replacement; Aortic stenosis; Low-flow low-
            Published online: December 10,   gradient aortic stenosis; Valvular heart disease
            2024
            Copyright: © 2024 Author(s).
            This is an Open-Access article
            distributed under the terms of the
            Creative Commons Attribution   1. Introduction
            License, permitting distribution,
            and reproduction in any medium,   Transcatheter aortic valve replacement (TAVR) has emerged as an invaluable alternative
            provided the original work is   to surgical aortic valve replacement (SAVR) in patients with aortic stenosis (AS) across
            properly cited.             the spectrum of surgical risk.  The need for valve replacement depends on AS severity. AS
                                                              1
            Publisher’s Note: AccScience   severity is assessed based on echocardiographic parameters, including peak and mean
            Publishing remains neutral with   velocities and gradients and aortic valve area (AVA). Although classical high-gradient AS
                                                                                2
            regard to jurisdictional claims in                                                       2
            published maps and institutional   (HGAS) is diagnosed based on a mean gradient of ≥40 mmHg, AVA of ≤1.0 cm , and peak
                                                     2
            affiliations.               velocity of ≥4 m /s, these measurements are not infrequently discordant. Discordant AS

            Volume 3 Issue 1 (2025)                         1                                doi: 10.36922/bh.4017
   2   3   4   5   6   7   8   9   10   11   12